Global Hepatitis B and C Diagnostics Market

Transcription

1 Global Hepatitis B and C Diagnostics Market

2 Global Hepatitis B and C Diagnostics Market BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 Global Hepatitis B and C Diagnostics Market About Hepatitis B and Hepatitis C Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-hcv serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening. Technavio s analysts forecast the global hepatitis B and C diagnostics market to grow at a CAGR of 6.35% during the period Covered in this report The report covers the present scenario and the growth prospects of the global hepatitis B and C diagnostics market for To calculate the market size, the report considers revenue generated from the sales of immunodiagnostics and nucleic acid test (NAT) instruments and consumables to hospitals, diagnostic centers, and research institutes. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Hepatitis B and C Diagnostics Market , has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors Abbott Diagnostics Roche Diagnostics Siemens Healthcare QIAGEN Other prominent vendors Affymetrix Allele Biotechnology Axis-Shield Becton Dickinson 3

4 biomérieux Cepheid Chembio Diagnostics DiaMetra DiaSorin Enzo Life Sciences Hologic ImmunoDX MedMira OraSure Technologies Quest Diagnostics Quidel Randox Laboratories Vela Diagnostics Vital Diagnostics ZEUS Scientific Market driver Strategies of healthcare organizations toward simplifying the diagnostic process For a full, detailed list, view our report Market challenge Regulatory and reimbursement hurdles limit the adoption rate For a full, detailed list, view our report Market trend Advent of immunosensors in the HBV and HCV diagnostic tests For a full, detailed list, view our report Key questions answered in this report What will the market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving this market? 4

5 What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst s time when you purchase this market report. Details are provided within the report. Additional Details Publisher : Technavio Reference : IRTNTR10208 Number of Pages : 110 Report Format : PDF Publisher Information : 5

6 Table Of Contents for Global Hepatitis B and C Diagnostics Market PART 01: Executive summary HighlightsPART 02: Scope of the report Market overview Top-vendor offeringspart 03: Market research methodology Research methodology Economic indicatorspart 04: Introduction Key market highlights Hepatitis B and C diagnostics: An overview Hepatitis B disease overview Hepatitis C disease overviewpart 05: Reimbursement scenario: An overviewpart 06: Market landscape Market overview Global hepatitis B and C diagnostics market overview Five forces analysispart 07: Market segmentation by procedure Immunodiagnostics Immunofluorescence Instruments Reagents Global hepatitis B and C immunodiagnostics market overview NAT Global hepatitis B and C NAT market overviewpart 08: Market segmentation by disease Hepatitis B Global hepatitis B diagnostics market overview Hepatitis C Global hepatitis C diagnostics market overviewpart 09: Geographical segmentation Hepatitis B and C diagnostics market in Americas Hepatitis B and C diagnostics market in EMEA Hepatitis B and C diagnostics market in APACPART 10: Market drivers Growing demand for molecular diagnostics in the diagnosis of HBV and HCV Strategies of healthcare organizations toward simplifying the diagnostic process Rising demand for POC diagnostics Increase in demand for automation and system integrationpart 11: Impact of driverspart 12: Market challenges Presence of high undiagnosed individuals Limited detection capability and complexity of assays Regulatory and reimbursement hurdles limit the adoption rate Limitations of closed systemspart 13: Impact of drivers and challengespart 14: Market trends Advent of immunosensors in the HBV and HCV diagnostic tests Paradigm shift toward the use of hepatitis C core antigen test High demand for biomarker-based testspart 15: Vendor landscape Competitive scenario Key newspart 16: Key vendor analysis Abbott Diagnostics Roche Diagnostics Siemens Healthcare QIAGEN Other prominent vendorspart 17: Appendix List of abbreviationspart 18: Explore TechnavioList of ExhibitsExhibit 01: Product offeringsexhibit 02: Possible outcomes of HBV infectionexhibit 03: Concentration of HBV in several body fluidsexhibit 04: Pathway of hepatitis B progressionexhibit 05: Disease progression of hepatitis BExhibit 06: Significance of serological markersexhibit 07: Types of hepatitis B diagnostic testsexhibit 08: Diagnostic strategies for HBVExhibit 09: Interpretation of serological markersexhibit 10: Endemicity pattern of hepatitis B across different regionsexhibit 11: Medical cost for chronic viral hepatitisexhibit 12: Progression of hepatitis CExhibit 13: Risk factors for hepatitis transmissionexhibit 14: Screening tests for hepatitis C infectionexhibit 15: Medical cost for hepatitis C and related infectionsexhibit 16: Reimbursement perspectives of healthcare entitiesexhibit 17: Global hepatitis B and C diagnostics market analysis: Developed and emerging marketsexhibit 18: Snapshot of global hepatitis B and C diagnostics marketexhibit 19: Global hepatitis B and C diagnostics market ($ billions)exhibit 20: Opportunity analysis of hepatitis B and C diagnostics marketexhibit 21: Five forces analysisexhibit 22: Global hepatitis B and C diagnostics market by procedure Exhibit 23: Global hepatitis B and C diagnostics market by procedure 2015 ($ billions)exhibit 24: Global hepatitis B and C diagnostics market by procedure: Lifecycle analysis 2015Exhibit 25: Global hepatitis B and C immunodiagnostics market ($ billions)exhibit 26: Opportunity analysis of immunodiagnosticsexhibit 27: Global hepatitis B and C immunodiagnostics market segmentation by product type 2015Exhibit 28: Global hepatitis B and C NAT market ($ millions)exhibit 29: Global hepatitis B and C NAT market segmentation by product type 2015Exhibit 30: Opportunity analysis of global hepatitis B and C NAT marketexhibit 31: Global hepatitis B and C diagnostics market segmentation by procedure ($ millions)exhibit 32: Global hepatitis B and C diagnostics market segmentation by procedure (%)Exhibit 33: Global hepatitis B and C diagnostics market segmentation: Impact analysis Exhibit 34: Global hepatitis B and C diagnostics market by disease type Exhibit 35: Global hepatitis B and C diagnostics market by disease type 2015Exhibit 36: Global hepatitis B and C diagnostics market by disease type: Lifecycle analysis 2015Exhibit 37: Acute hepatitis B infection by demography 2015Exhibit 38: Chronic hepatitis B infection by demography 2015Exhibit 39: Procurement of hepatitis B diagnostic kits by WHO 2015Exhibit 40: Global hepatitis B diagnostics market ($ millions)exhibit 41: Opportunity analysis of global hepatitis B diagnostics marketexhibit 42: Prevalence rates of hepatitis C across different regions 2015Exhibit 43: Treatment cost of hepatitis C-related infectionsexhibit 44: Procurement of hepatitis C diagnostic kits by WHO 2015Exhibit 45: Opportunity analysis of hepatitis CExhibit 46: Global hepatitis C diagnostics market ($ billions)exhibit 47: Global hepatitis B and C diagnostics market by disease type ($ millions)exhibit 48: Global hepatitis B and C diagnostics market by disease type (%)Exhibit 49: Global hepatitis B and C diagnostics segmentation by disease 6

7 typeexhibit 51: Geographical hepatitis B and C diagnostics market 2015Exhibit 52: Global hepatitis B and C diagnostics: Regional market lifecycle analysisexhibit 53: Global hepatitis B and C diagnostics market by geography Exhibit 54: Global hepatitis and C diagnostics market segmentation by geography 2015Exhibit 55: Global hepatitis B and C diagnostics market by geography lifecycle analysis 2015Exhibit 56: Hepatitis B and C diagnostics in Americas 2015Exhibit 57: Prevalence data of hepatitis C in North AmericaExhibit 58: Prevalence data of hepatitis C in Latin AmericaExhibit 59: Hepatitis B and C diagnostics market in Americas ($ billions)exhibit 60: Prevalence data of hepatitis C in EuropeExhibit 61: Hepatitis B and C diagnostics market in EMEA ($ billions)exhibit 62: Prevalence rate of hepatitis B in APACExhibit 63: Prevalence data of hepatitis C in APACExhibit 64: Hepatitis B and C diagnostics market in EMEA ($ billions)exhibit 65: Global hepatitis B and C diagnostics market by geography ($ millions)exhibit 66: Global hepatitis B and C diagnostics market by geography (%)Exhibit 67: Global hepatitis B and C diagnostics market by geographyexhibit 68: Strategies of healthcare organizationsexhibit 69: Advantages of POC diagnosticsexhibit 70: Recent and expected product launches of HCV POC diagnostic testsexhibit 71: Impact of driversexhibit 72: Prevalence and diagnosis of HCV infections across developing countries 2015 (millions)exhibit 73: Key factors affecting the adoption ratesexhibit 74: Force field analysis of global hepatitis b and C diagnostics marketexhibit 75: Impact of drivers and challengesexhibit 76: Key advantages driving the adoption of HCV core antigen testexhibit 77: Impact of trends on global hepatitis B and C diagnostics market Exhibit 78: Key leading vendors ranking for instruments 2015Exhibit 79: Presence of vendors in the global hepatitis B and C diagnostics marketexhibit 80: Abbott Laboratories: Key business offeringsexhibit 81: Abbott Diagnostics: Metric analysisexhibit 82: Hoffmann-La Roche: Business segmentation by revenue 2015Exhibit 83: Roche Diagnostics: Products and descriptionexhibit 84: Roche Diagnostics: Business segmentation by revenue 2015Exhibit 85: Roche Diagnostics: Metric analysisexhibit 86: Siemens Healthcare: Various tests available in multiple diseasesexhibit 87: Siemens Healthcare: Metric analysisexhibit 88: QIAGEN: Metric analysis 7

8 How to Buy... Global Hepatitis B and C Diagnostics Market Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $2500 Single User Price $3000 Five User License Price $4000 Enterprise License Price $10000 Global License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 8